SUPPLIER SeraCare

SeraCare

In 2015, SeraCare expanded their R&D facility and announced the formation of a new ''Precision Medicine' business unit focused on the development of technologies and products to enable the safe and effective expansion of precision medicine-driven diagnostics.

Since then, novel products for oncology, reproductive health, infectious disease and inherited disease have emerged from the SeraCare pipeline to support our clients’ development and validation efforts for precision medicine diagnostics. During this time, Seraseq technology was introduced to develop high-quality reference materials for next-generation sequencing applications.

SeraCare – New Tools for Clinical Genomics Assay

Next-generation sequencing (NGS) has revolutionized the field of genomics and how in vitro diagnostic (IVD) test developers, laboratories, and clinicians are diagnosing, treating, and monitoring disease. Before successfully launching a clinical assay, platform, or service, the tests must undergo rigorous development and thorough validation to ensure accuracy of the result.

SeraCare’s Seraseq™ comprehensive solution pairs highly consistent, quantitative, and highly multiplexed reference materials with easy-to-use software to greatly speed and simplify the capture and tracking of QC metrics.

Wide Range of Reference Materials

  • Oncology
  • Reproductive health
  • Inherited disease
  • Infectious disease

For Every Phase of Clinical NGS Assay

  • Assay Development
  • Assay Validation
  • Laboratory QC

Clinically Relevant Formats

  • Proprietary technology for the most patient-like reference materials
  • FFPE cell lines to monitor and optimize your entire assay workflow
  • Expedite development and validation with purified mutation DNA and RNA mixes.

 Actionable Variants

  • Expert-designed constructs with a mix of common, rare, and challenging variants
  • Range of variant types includes single nucleotide variants (SNVs), insertion-deletion mutations (INDELs), structural rearrangements (CNVs), and gene fusions
  • Seraseq biosynthetic technology can precisely modulate allele frequency, gene copy numbers, and fusion events for accurate assessment of assay LOD.

Consistent Reference Material

  • Highly multiplexed material with up to 40 variants in a single sample to maximize data output from each sequencing run
  • Digital PCR ensures precise quantitation
  • Manufactured in GMP-compliant and ISO 13485-certified facilities for consistency across time and material lots.
Filter
Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
2 From 2
Item No. Short Description Content
0710-0208 Seraseq™ ctDNA Reference Material v2 Full-Process, WT VIAL (5 ml at 25 ng/ ml)
0710-0204 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 1% VIAL (5 ml at 25 ng/ ml)
0710-0203 Seraseq™ ctDNA Reference Material v2 Full-Process, AF 2% VIAL (5 ml at 25 ng/ ml)
0740-0025 Seraseq™ HIV DR & Tropism RF v2 (5x10^4 viral copies, MF 40%) 1x1.0 ml
0740-0026 Seraseq™ HIV DR & Tropism RF v2 (5x10^4 viral copies, MF 1/5/20%) 1x1.0 ml
0740-0011 Seraseq™ HIV-1 2529-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0012 Seraseq™ HIV-1 2808-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0010 Seraseq™ HIV-1 7384-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0009 Seraseq™ HIV-1 7388-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0006 Seraseq™ HIV-1 93/US/141-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0005 Seraseq™ HIV-1 93/US/143-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0002 Seraseq™ HIV-1 93/US/144-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0001 Seraseq™ HIV-1 BK132-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0008 Seraseq™ HIV-1 CM235-CRF01_AE Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0003 Seraseq™ HIV-1 CM237-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0007 Seraseq™ HIV-1 I-2496 CRF02_AG Reference Material (1x10^6 viral copies) 1x1.0 ml
0740-0004 Seraseq™ HIV-1 US1-B Reference Material (1x10^6 viral copies) 1x1.0 ml
0730-0003 Seraseq™ Inherited Cancer DNA Mix v1 Purified DNA AF 50% VIAL (200 uL at 50 ng/uL)
0710-0416 Seraseq™ Lung & Brain CNV Mix, +12 copies Purified DNA VIAL (20 uL at 10 ng/uL)
0710-0414 Seraseq™ Lung & Brain CNV Mix, +3 copies Purified DNA VIAL (20 uL at 10 ng/uL)
0710-0415 Seraseq™ Lung & Brain CNV Mix, +6 copies Purified DNA VIAL (20 uL at 10 ng/uL)
0710-0143 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.125% VIAL (25 uL at 10 ng/uL)
0710-0142 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.25% VIAL (25 uL at 10 ng/uL)
0710-0141 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 0.5% VIAL (25 uL at 10 ng/uL)
0710-0140 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 1% VIAL (25 uL at 10 ng/uL)
0710-0139 Seraseq™ ctDNA Mutation Mix v2 Purified DNA AF 2% VIAL (25 uL at 10 ng/uL)
0710-0144 Seraseq™ ctDNA Mutation Mix v2 Purified DNA WT VIAL (25 uL at 10 ng/uL)
0710-0407 Seraseq™ Myeloid Fusion RNA Mix Purified RNA VIAL (25 uL at 15 ng/uL)
0710-0408 Seraseq™ Myeloid Mutation DNA Mix Purified DNA AF 5/10/15% VIAL (25 uL at 15 ng/uL)
0710-0497 Seraseq™ Fusion RNA Mix, v4 Purified RNA VIAL (25 uL at 25 ng/uL)
0720-0172 Seraseq® Trisomy 18 Female Matched Reference Material VIAL (1 ml at 20 ng/ ml)
0720-0168 Seraseq® Trisomy 21 Female Matched Reference Material VIAL (1 ml at 20 ng/ ml)
0720-0167 Seraseq® Trisomy 21 Male Matched Reference Material VIAL (1 ml at 20 ng/ ml)
0710-0496 Seraseq™ FFPE Tumor Fusion RNA Reference Material v4 1 FFPE Curl / Tube
0710-1309 Seraseq® FFPE Tumor Mutational Burden Reference Material Score 20 1 FFPE Curl / Tube
0710-1307 Seraseq® FFPE Tumor Mutational Burden Reference Material Score 26 1 FFPE Curl / Tube
0710-1310 Seraseq® FFPE Tumor Mutational Burden Reference Material Score 7 1 FFPE Curl / Tube
0710-1308 Seraseq® FFPE Tumor Mutational Burden Reference Material Score 9 1 FFPE Curl / Tube
0710-1325 Seraseq® Genomic DNA Tumor Mutational Burden Mix, Score 20 Purif. DNA (tumor & matching normal), h. cell line VIAL (10 uL at 50 ng/uL)
0710-1323 Seraseq® Genomic DNA Tumor Mutational Burden Mix, Score 26 Purif. DNA (tumor & matching normal), h. cell line VIAL (10 uL at 50 ng/uL)
0710-1326 Seraseq® Genomic DNA Tumor Mutational Burden Mix, Score 7 Purif. DNA (tumor & matching normal), h. cell line VIAL (10 uL at 50 ng/uL)
0710-1324 Seraseq® Genomic DNA Tumor Mutational Burden Mix, Score 9 Purif. DNA (tumor & matching normal), h. cell line VIAL (10 uL at 50 ng/uL)
0710-0094 Seraseq™ Tumor Mutation DNA Mix v2 Purified DNA HC, AF 10% VIAL (25 uL at 25 ng/uL)
0710-0095 Seraseq™ Tumor Mutation DNA Mix v2 Purified DNA HC, AF 7% VIAL (25 uL at 25 ng/uL)
0710-0097 Seraseq™ Tri-Level Tumor Mutation Purified DNA HC, AF 4/7/10% VIAL (25 uL at 25 ng/uL)
0710-0137 Seraseq™ FFPE WT (DNA/RNA) Reference Material 1 FFPE Curl / Tube
2 From 2